Inhibition of c-mycExpression in Cells by Targeting an RNA-Protein Interaction Using Antisense Oligonucleotides
- 1 March 2000
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 57 (3) , 485-494
- https://doi.org/10.1124/mol.57.3.485
Abstract
Antisense oligodeoxynucleotides (ODNs) are designed to bind to and inhibit a target mRNA. We used a novel approach for the design of ODNs to the c-myc mRNA using protein binding sites as targets for ODN action. Our strategy was to identify ODNs that could interfere with the coding region determinant-binding protein (CRD-BP), a protein that binds to the CRD region of the c-myc mRNA. Using an in vitro gel shift assay, we show that ODN molecules can occlude the CRD-BP from the mRNA. The best ODN, CRD-ODN4, was able to inhibit RNA binding of the CRD-BP by 75%. This effect was sequence-specific and concentration dependent. K562 cells treated with a 2′-O-methyl derivative of CRD-ODN4 showed a concentration-dependent decrease in both c-myc mRNA and protein levels, with a maximal 65% inhibition of protein expression at 200 nM CRD-ODN4. In contrast, a 2′-O-methyl ODN derivative targeting the translation initiation codon (antimyc-aug) reduced c-myc protein but actually increased mRNA levels, an effect resulting at least partly from stabilization of the c-myc mRNA. CRD-ODN4 treatment did not alter the c-myc mRNA half-life. CRD-ODN4 was more effective in inhibiting K562 cell growth than antimyc-aug, reducing cell number by ≈70% after 48 h of exposure to 750 nM. The correlation between ODN effects on RNA-protein interactions in vitro and those observed in cells supports the hypothesis that CRD-ODN4 inhibits the interaction between the CRD-BP and the c-myc mRNA and that disrupting this RNA-protein interaction reduces c-mycexpression in cells.Keywords
This publication has 40 references indexed in Scilit:
- Tetranucleotide GGGA Motif in Primary RNA TranscriptsPublished by Elsevier ,1998
- Purification and Characterization of a Polysome-associated Endoribonuclease That Degrades c-myc mRNA in VitroPublished by Elsevier ,1998
- Developmental regulation of CRD-BP, an RNA-binding protein that stabilizes c-myc mRNA in vitroOncogene, 1997
- Antitumor Effect of c-myc Antisense Phosphorothioate Oligodeoxynucleotides on Human Melanoma Cells In Vitro and in MiceJNCI Journal of the National Cancer Institute, 1996
- Cytoplasmic mRNA-protein interactions in eukaryotic gene expressionTrends in Biochemical Sciences, 1995
- Gene inhibition using antisense oligodeoxynucleotidesNature, 1994
- Sequences responsible for intracellular localization of beta-actin messenger RNA also affect cell phenotype.The Journal of cell biology, 1994
- Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?Science, 1993
- Control of c-myc mRNA half-life in vitro by a protein capable of binding to a coding region stability determinant.Genes & Development, 1992
- THE myc ONCOGENE: ITS ROLE IN TRANSFORMATION AND DIFFERENTIATIONAnnual Review of Genetics, 1986